Profil
Mahima Datla is currently the Managing Director & Director at Biological E.
Ltd.
and also holds the position of Director at Global Health Innovative Technology Fund.
Aktive Positionen von Mahima Datla
| Unternehmen | Position | Beginn |
|---|---|---|
Biological E. Ltd.
 Biological E. Ltd. Pharmaceuticals: MajorHealth Technology Biological E. Ltd. operates as a biological products company. It manufactures liver extracts and anti-coagulants. The company was founded by Datla Venkata Krishnam Raju in 1953 and is headquartered in Hyderabad, India. | Vorstandsvorsitzender | - |
Global Health Innovative Technology Fund
 Global Health Innovative Technology Fund Investment ManagersFinance Global Health Innovative Technology Fund provides funding of scientific research and development for anti-infectives and diagnostics for diseases that affect the developing world. Its activities include facilitation of global research and development partnerships for the discovery and development of new health technologies for the developing world, investment in these global research and development partnerships through a grant-making mechanism and advancement of Japan’s contribution to global health. The company is headquartered in Minato-ku, Japan. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Biological E. Ltd.
Biological E. Ltd. Pharmaceuticals: MajorHealth Technology Biological E. Ltd. operates as a biological products company. It manufactures liver extracts and anti-coagulants. The company was founded by Datla Venkata Krishnam Raju in 1953 and is headquartered in Hyderabad, India. | Health Technology |
Global Health Innovative Technology Fund
Global Health Innovative Technology Fund Investment ManagersFinance Global Health Innovative Technology Fund provides funding of scientific research and development for anti-infectives and diagnostics for diseases that affect the developing world. Its activities include facilitation of global research and development partnerships for the discovery and development of new health technologies for the developing world, investment in these global research and development partnerships through a grant-making mechanism and advancement of Japan’s contribution to global health. The company is headquartered in Minato-ku, Japan. | Finance |
